生物製剤の高濃度によって特徴づけられる穿通性寛解はクロン病においてより良い予後を示す

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Tumor necrosis factor antagonist mechanisms of action: A comprehensive review2007 · 1,618 citations
2. 2The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications2006 · 3,156 citations
3. 3Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease2019 · 216 citations
4. 4Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn’s disease2020 · 86 citations
5. 5Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics2014 · 84 citations